Free Trial
→ How one gold strategy paid out 1127 dollars in a month (From Investors Alley) (Ad)tc pixel Free CNBX Stock Alerts
OTCMKTS:CNBX

CNBX Pharmaceuticals (CNBX) Stock Price, News & Analysis

CNBX Pharmaceuticals logo
$0.0002 +0.00 (+100.00%)
As of 11/4/2026 03:54 PM Eastern
Compare

About CNBX Pharmaceuticals Stock (OTCMKTS:CNBX)

View Price History Chart DataSkip Price History Chart
Advanced
1 Day 5 Days 30 Days 90 Days 1 Year
Advanced

Key Stats

Today's Range
$0.0001
▼
$0.0002
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0007
Volume
544,925 shs
Average Volume
23.68 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CNBX Pharmaceuticals, Inc. is a biotechnology company focused on developing cannabinoid-based pharmaceutical products and treatments. Its research has centered on the potential use of medical cannabis compounds in oncology and other therapeutic applications.

The company has worked on technologies designed to evaluate how individual cancer cells respond to different cannabinoid formulations. Its development activities have included cannabinoid-based oral products and personalized-treatment approaches intended to help identify potentially effective therapies for specific patients.

CNBX Pharmaceuticals has historically operated from Israel and has been associated with Cannabics Pharmaceuticals, the name under which some of its earlier research and product-development activities were conducted. Publicly available information about its current commercial operations, product availability, and leadership is limited.

AI Generated. May Contain Errors.

Receive CNBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CNBX Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNBX Stock News Headlines

Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research
July 29, 2026  |  nasdaq.comhttps://www.nasdaq.com/press-release/cannabics-pharmaceuticals-announces-the-appointment-of-dr.-yaakov-waksman-as-head-of
CNBX Pharmaceuticals Inc. (CNBX) stock forecast and price target
July 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/research/stock-forecast/CNBX/
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
 |  Behind the Markets (Ad)
CNBX Pharmaceuticals (OTC:CNBX) Stock Quotes, Forecast and News Summary
March 1, 2025  |  benzinga.comhttps://www.benzinga.com/quote/CNBX
CNBX Pharmaceuticals Stock (OTC:CNBX) Dividends: History, Yield and Dates
November 24, 2023  |  benzinga.comhttps://www.benzinga.com/quote/CNBX/dividend
CNBX Pharmaceuticals Inc CNBX
November 5, 2023  |  morningstar.comM
CNBX Historical Data
October 9, 2023  |  investing.comhttps://www.investing.com/equities/cannabics-pharmaceuticals-inc-historical-data
CNBX - CNBX Pharmaceuticals Inc.
July 28, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/quote/CNBX/history/
See More Headlines

CNBX Stock Analysis - Frequently Asked Questions

CNBX Pharmaceuticals' stock was trading at $0.0004 on January 1st, 2026. Since then, CNBX shares have decreased by 50.0% and is now trading at $0.0002.

Shares of CNBX Pharmaceuticals reverse split on the morning of Thursday, May 12th 2022.The 1-120 reverse split was announced on Thursday, May 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of CNBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CNBX Pharmaceuticals investors own include Cronos Group (CRON), Medical Marijuana (MJNA), Micron Technology (MU), Organigram Global (OGI), American Cannabis (AMMJ), Aurora Cannabis (ACB) and Kushco (KSHB).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:CNBX
CIK
1343009
Web
cnbxpharma.com
Phone
(877) 424-2429
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (OTCMKTS:CNBX) was last updated on 11/4/2026 by MarketBeat.com Staff.
From Our Partners
The 401k Email 70 Million Investors Might Delete
An email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...
Brownstone Research | Sponsoredtc pixel
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...
Weiss Ratings | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...
Behind the Markets | Sponsoredtc pixel
Don't lose access to this
Ian Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...
TradeWins | Sponsoredtc pixel
This little-known fund tracks gold and pays out weekly
A little-known $15 fund tied to gold could pay you cash every Friday, no mining stock required. In one rece...
Investors Alley | Sponsoredtc pixel
$29.97 or $0 today
The 0DTE Game Plan normally sells for 29.97, but it is free today through this link. Inside is a straightfo...
Profits Run | Sponsoredtc pixel